Michael Feldman - Publications

Affiliations: 
1955-2005 Weizmann Institute of Science, Rehovot, Israel 
Area:
cancer research, cellular immunology, developmental biology
Website:
https://www.academy.ac.il/Index2/Entry.aspx?nodeId=835&entryId=18279

154 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Ruella M, Klichinsky M, Kenderian SS, Shestova O, Ziober A, Kraft DO, Feldman M, Wasik MA, June CH, Gill S. Overcoming the Immunosuppressive Tumor Microenvironment of Hodgkin Lymphoma Using Chimeric Antigen Receptor T Cells. Cancer Discovery. PMID 28576927 DOI: 10.1182/Blood.V128.22.43.43  0.363
2016 Posey AD, Schwab RD, Boesteanu AC, Steentoft C, Mandel U, Engels B, Stone JD, Madsen TD, Schreiber K, Haines KM, Cogdill AP, Chen TJ, Song D, Scholler J, Kranz DM, Feldman MD, et al. Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma. Immunity. 44: 1444-1454. PMID 27332733 DOI: 10.1016/J.Immuni.2016.05.014  0.324
2016 Bhoj VG, Arhontoulis D, Wertheim G, Capobianchi J, Callahan CA, Ellebrecht CT, Obstfeld AE, Lacey SF, Melenhorst JJ, Nazimuddin F, Hwang WT, Maude SL, Wasik MA, Bagg A, Schuster S, ... Feldman MD, et al. Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T cell therapy. Blood. PMID 27166358 DOI: 10.1182/Blood-2016-01-694356  0.309
2015 Wang E, Wang LC, Tsai CY, Bhoj V, Gershenson Z, Moon E, Newick K, Sun J, Lo A, Baradet T, Feldman MD, Barrett D, Puré E, Albelda S, Milone MC. Generation of Potent T-cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric Immunoreceptors. Cancer Immunology Research. 3: 815-26. PMID 25941351 DOI: 10.1158/2326-6066.Cir-15-0054  0.335
2014 Motz GT, Santoro SP, Wang LP, Garrabrant T, Lastra RR, Hagemann IS, Lal P, Feldman MD, Benencia F, Coukos G. Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors. Nature Medicine. 20: 607-15. PMID 24793239 DOI: 10.1038/Nm.3541  0.301
2010 Tsygankova OM, Ma C, Tang W, Korch C, Feldman MD, Lv Y, Brose MS, Meinkoth JL. Downregulation of Rap1GAP in human tumor cells alters cell/matrix and cell/cell adhesion. Molecular and Cellular Biology. 30: 3262-74. PMID 20439492 DOI: 10.1128/Mcb.01345-09  0.326
2007 Domchek SM, Recio A, Mick R, Clark CE, Carpenter EL, Fox KR, DeMichele A, Schuchter LM, Leibowitz MS, Wexler MH, Vance BA, Beatty GL, Veloso E, Feldman MD, Vonderheide RH. Telomerase-specific T-cell immunity in breast cancer: effect of vaccination on tumor immunosurveillance. Cancer Research. 67: 10546-55. PMID 17974999 DOI: 10.1158/0008-5472.Can-07-2765  0.301
2000 Carmon L, El-Shami KM, Paz A, Pascolo S, Tzehoval E, Tirosh B, Koren R, Feldman M, Fridkin M, Lemonnier FA, Eisenbach L. Novel breast-tumor-associated MUC1-derived peptides: Characterization in D(b-)/- x β2 microglobulin (β2m) null mice transgenic for a chimeric HLA- A2.1/D(b)-β2 microglobulin single chain International Journal of Cancer. 85: 391-397. PMID 10652432 DOI: 10.1002/(Sici)1097-0215(20000201)85:3<391::Aid-Ijc16>3.0.Co;2-V  0.346
2000 El-Shami KM, Tirosh B, Popovic D, Carmon L, Tzehoval E, Vadai E, Feldman M, Eisenbach L. Induction of antitumor immunity by proteasome-inhibited syngeneic fibroblasts pulsed with a modified TAA peptide International Journal of Cancer. 85: 236-242. PMID 10629083 DOI: 10.1002/(Sici)1097-0215(20000115)85:2<236::Aid-Ijc14>3.0.Co;2-5  0.406
1999 Tirosh B, el-Shami K, Vaisman N, Carmon L, Bar-Haim E, Vadai E, Feldman M, Fridkin M, Eisenbach L. Immunogenicity of H-2Kb-low affinity, high affinity, and covalently-bound peptides in anti-tumor vaccination. Immunology Letters. 70: 21-8. PMID 10541048 DOI: 10.1016/S0165-2478(99)00115-7  0.324
1999 El-Shami K, Tirosh B, Bar-Haîm E, Carmon L, Vadai E, Fridkin M, Feldman M, Eisenbach L. MHC class I-restricted epitope spreading in the context of tumor rejection following vaccination with a single immunodominant CTL epitope European Journal of Immunology. 29: 3295-3301. PMID 10540341 DOI: 10.1002/(Sici)1521-4141(199910)29:10<3295::Aid-Immu3295>3.0.Co;2-N  0.466
1998 SELA M, FUCHS S, FELDMAN M. Specific immunologic unresponsiveness to synthetic polypeptide antigens. Science (New York, N.Y.). 139: 342-3. PMID 13992691 DOI: 10.1126/Science.139.3552.342  0.375
1998 Popovic D, El-Shami KM, Vadai E, Feldman M, Tzehoval E, Eisenbach L. Antimetastatic vaccination against Lewis lung carcinoma with autologous tumor cells modified to express murine interleukin 12 Clinical and Experimental Metastasis. 16: 623-632. PMID 9932609 DOI: 10.1023/A:1006508413070  0.41
1998 Eisenbach L, Mandelboim O, Bar-Haim E, Carmon L, Copcow H, El-Shami K, Paz A, Popovic D, Vadai E, Tzehoval E, Feldman M, Fridkin M. Tumor-associated antigen peptides as anti-metastatic vaccines Letters in Peptide Science. 5: 323-328. DOI: 10.1007/Bf02443479  0.381
1997 Fitzer-Attas CJ, Do MS, Feigelson S, Vadai E, Feldman M, Eisenbach L. Modification of PDGFα receptor expression or function alters the metastatic phenotype of 3LL cells Oncogene. 15: 1545-1554. PMID 9380406 DOI: 10.1038/Sj.Onc.1201321  0.334
1996 Lachgar A, Bernard J, Bizzini B, Astgen A, Le Coq H, Fouchard M, Chams V, Feldman M, Burny A, Zagury JF. Repair of the in vitro HIV-1-induced immunosuppression and blockade of the generation of functional suppressive CD8 cells by anti-alpha interferon and anti-Tat antibodies Biomedicine and Pharmacotherapy. 50: 13-18. PMID 8672726 DOI: 10.1016/0753-3322(96)85092-X  0.386
1995 Feldman M. From aristotle, through spemann, to tumor immunology: A personal experience Advances in Cancer Research. 66: 41-70. PMID 7793320 DOI: 10.1016/S0065-230X(08)60251-1  0.478
1995 Mandelboim O, Vadai E, Fridkin M, Katz-Hillel A, Feldman M, Berke G, Eisenbach L. Regression of established murine carcinoma metastases following vaccination with tumour-associated antigen peptides Nature Medicine. 1: 1179-1183. PMID 7584991 DOI: 10.1038/Nm1195-1179  0.312
1995 Revel M, Katz A, Eisenbach L, Feldman M, Haran-Ghera N, Harroch S, Chebath J. Interleukin-6: Effects on tumor models in mice and on the cellular regulation of transcription factor IRF-1 Annals of the New York Academy of Sciences. 762: 342-356. PMID 7545371 DOI: 10.1111/J.1749-6632.1995.Tb32338.X  0.312
1994 Mandelboim O, Berke G, Fridkin M, Feldman M, Eisenstein M, Eisenbach L. CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma Nature. 369: 67-71. PMID 8164742 DOI: 10.1038/369067A0  0.347
1994 Plaksin D, Porgador A, Vadai E, Feldman M, Schirrmacher V, Eisenbach L. Effective anti-metastatic melanoma vaccination with tumor cells transfected with MHC genes and/or infected with Newcastle disease virus (NDV) International Journal of Cancer. 59: 796-801. PMID 7989121 DOI: 10.1002/Ijc.2910590615  0.401
1993 Katz A, Shulman LM, Revel M, Feldman M, Eisenbach L. Combined therapy with IL-6 and inactivated tumor cells suppresses metastasis in mice bearing 3LL lung carcinomas International Journal of Cancer. 53: 812-818. PMID 8449606 DOI: 10.1002/Ijc.2910530518  0.415
1993 Porgador A, Gansbacher B, Bannerji R, Tzehoval E, Gilboa E, Feldman M, Eisenbach L. Anti-metastatic vaccination of tumor-bearing mice with IL-2-gene-inserted tumor cells International Journal of Cancer. 53: 471-477. PMID 8428800 DOI: 10.1002/Ijc.2910530320  0.359
1993 Fitzer-Attas C, Feldman M, Eisenbach L. Expression of functionally intact PDGF-α receptors in highly metastatic 3LL Lewis lung carcinoma cells International Journal of Cancer. 53: 315-322. PMID 8425771 DOI: 10.1002/Ijc.2910530224  0.379
1993 Katz A, Shulman LM, Porgador A, Revel M, Feldman M, Eisenbach L. Abrogation of b16 melanoma metastases by long-term low-dose interleukin-6 therapy Journal of Immunotherapy. 13: 98-109. PMID 8318501 DOI: 10.1097/00002371-199302000-00004  0.36
1993 Zagury JF, Bernard J, Achour A, Astgen A, Lachgar A, Fall L, Carelli C, Issing W, Mbika JP, Cantalloube H, Picard O, Gourbil A, Guignon JM, Cozette J, Faure JP, ... ... Feldman M, et al. HIV-1-induced immune suppression may result from autoimmune disorders including anti-SLWDQ autoantibodies Biomedicine and Pharmacotherapy. 47: 93-99. PMID 8218954 DOI: 10.1016/0753-3322(93)90297-X  0.421
1992 Katz A, Feldman M, Eisenbach L. The use of [35S]methionine as a target cell label in long term cytotoxic assays Journal of Immunological Methods. 149: 255-260. PMID 1593137 DOI: 10.1016/0022-1759(92)90257-T  0.388
1991 Porgador A, Brenner B, Vadai E, Feldman M, Eisenbach L. Immunization by gamma-IFN-treated B16-F10.9 melanoma cells protects against metastatic spread of the parental tumor International Journal of Cancer. 48: 54-60. PMID 1906054 DOI: 10.1002/Ijc.2910470713  0.383
1991 Gelber C, Eisenbach L, Feldman M, Goodenow RS. T-cell subset analysis of 3LL tumor growth International Journal of Cancer. 48: 69-72. PMID 1829721 DOI: 10.1002/Ijc.2910470715  0.438
1990 Kushtai G, Feldman M, Eisenbach L. Transfection of 3LL tumor cells turns on MHC gene expression and consequently reduces their metastatic competence International Journal of Cancer. 45: 1131-1136. PMID 2351488 DOI: 10.1002/Ijc.2910450624  0.325
1989 Porgador A, Feldman M, Eisenbach L. H-2Kb transfection of B16 melanoma cells results in reduced tumourigenicity and metastatic competence Journal of Immunogenetics. 16: 291-303. PMID 2639904 DOI: 10.1111/J.1744-313X.1989.Tb00475.X  0.375
1989 Tzehoval E, Dagan S, Eisenbach L, Atsmon J, Feldman M. Immunogenic capacity of macrophage hybridomas European Journal of Immunology. 19: 89-96. PMID 2465907 DOI: 10.1002/Eji.1830190115  0.419
1988 Feldman M, Eisenbach L. What makes a tumor cell metastatic? Scientific American. 259: 60-65, 68, 85. PMID 2463669 DOI: 10.1038/Scientificamerican1188-60  0.401
1986 Hammerling GJ, Klar D, Katzav S, Segal S, Feldman M, Wallich R, Hämmerling A. Manipulation of metastasis and tumour growth by transfection with histocompatibility class I genes. International Journal of Immunogenetics. 13: 153-157. PMID 3819449 DOI: 10.1111/J.1744-313X.1986.Tb01096.X  0.302
1986 Dagan S, Gottlieb P, Tzehoval E, Feldman M, Fridkin M, Yasumura K, Okamoto K, Yajima H. Tuftsin analogues: synthesis, structure-function relationships, and implications for specificity of tuftsin's bioactivity. Journal of Medicinal Chemistry. 29: 1961-8. PMID 3761314 DOI: 10.1021/Jm00160A027  0.348
1986 Zagury D, Bernard J, Leonard R, Cheynier R, Feldman M, Sarin P, Gallo R. Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDS. Science. 231: 850-853. PMID 2418502 DOI: 10.1126/Science.2418502  0.413
1985 Wallich R, Bulbuc N, Hämmerling GJ, Katzav S, Segal S, Feldman M. Abrogation of metastatic properties of tumour cells by de novo expression of H-2K antigens following H-2 gene transfection Nature. 315: 301-305. PMID 3873616 DOI: 10.1038/315301A0  0.386
1985 Zagury D, Fouchard M, Vol J, Cattan A, Leibowitch J, Feldman M, Sarin P, Gallo R. Detection Of Infectious Htlv-Iii/Lav Virus In Cell-Free Plasma From Aids Patients The Lancet. 326: 505-506. PMID 2863528 DOI: 10.1016/S0140-6736(85)90442-8  0.309
1984 Katzav S, Segal S, Feldman M. Immuno‐selection In vivo of H‐2D phenotypic variants from a metastatic clone of sarcoma cells results in cell lines of altered metastatic competence International Journal of Cancer. 33: 407-415. PMID 6698640 DOI: 10.1002/Ijc.2910330320  0.412
1984 Eisenbach L, Hollander N, Greenfeld L, Yakor H, Segal S, Feldman M. The differential expression of H-2K versus H-2D antigens, distinguishing high-metastatic from low-metastatic clones, is correlated with the immunogenic properties of the tumor cells. International Journal of Cancer. 34: 567-73. PMID 6490207 DOI: 10.1002/Ijc.2910340421  0.336
1984 Baetselier PD, Roos E, Brys L, Remels L, Gobert M, Dekegel D, Segal S, Feldman M. Nonmetastatic tumor cells acquire metastatic properties following somatic hybridization with normal cells. Cancer and Metastasis Reviews. 3: 5-24. PMID 6370419 DOI: 10.1007/Bf00047690  0.436
1984 Baetselier PD, Roos E, Brys L, Remels L, Feldman M. Generation of invasive and metastatic variants of a non-metastatic T-cell lymphoma by in vivo fusion with normal host cells. International Journal of Cancer. 34: 731-738. PMID 6334039 DOI: 10.1002/Ijc.2910340522  0.445
1984 Zagury D, Bernard J, Leibowitch J, Safai B, Groopman J, Feldman M, Sarngadharan M, Gallo R. HTLV-III in cells cultured from semen of two patients with AIDS Science. 226: 449-451. PMID 6208607 DOI: 10.1126/Science.6208607  0.422
1983 Tzehoval E, Segal S, Zinberg N, Tartakovsky B, Feldman M. Macrophage hybridomas: an approach to the analysis of the functional heterogeneity of macrophages. Advances in Experimental Medicine and Biology. 155: 445-51. PMID 7158495 DOI: 10.1007/978-1-4684-4394-3_46  0.412
1983 Feldman M, Tzehoval E, Ron Y, De Baetselier P, Fridkin M, Segal S. Mechanisms controlling differentiation and function of antigen-presenting macrophages. Advances in Experimental Medicine and Biology. 155: 543-8. PMID 6984283 DOI: 10.1007/978-1-4684-4394-3_58  0.426
1983 De Baetselier P, Gorelik E, Eshhar Z, Ron Y, Katsav S, Feldman M, Segal S. Organ-specific homing of B-cell hybridomas. Advances in Experimental Medicine and Biology. 149: 179-85. PMID 6983212 DOI: 10.1007/978-1-4684-9066-4_24  0.437
1983 Brodt P, Feldman M, Segal S. Differences in the metastatic potential of two sublines of tumor 3LL selected for resistance to natural NK-like effector cells Cancer Immunology, Immunotherapy. 16: 109-113. PMID 6607103 DOI: 10.1007/Bf00199241  0.465
1983 Zagury D, Bernard J, Morgan DA, Fouchard M, Feldman M. Phenotypic diversity within clones of human normal T cells. International Journal of Cancer. 31: 705-710. PMID 6602777 DOI: 10.1002/Ijc.2910310605  0.345
1983 Tzehoval E, Baetselier PD, Ron Y, Tartakovsky B, Feldman M, Segal S. Splenic B cells function as immunogenic antigenpresenting cells for the induction of effector T cells European Journal of Immunology. 13: 89-94. PMID 6601013 DOI: 10.1002/Eji.1830130202  0.493
1983 Ron Y, Baetselier PD, Tzehoval E, Gordon J, Feldman M, Segal S. Defective induction of antigen-reactive proliferating T cells in B cell-deprived mice II. Anti-μ treatment affects the initiation and recruitment of T cells European Journal of Immunology. 13: 167-171. PMID 6403358 DOI: 10.1002/Eji.1830130214  0.477
1983 Gottlieb P, Tzehoval E, Feldman M, Segal S, Fridkin M. Peptide fragments from the tuftsin containing domain of immunoglobulin G synthesis and biological activity Biochemical and Biophysical Research Communications. 115: 193-200. PMID 6311202 DOI: 10.1016/0006-291X(83)90988-9  0.303
1983 Zagury D, Morgan D, Lenoir G, Fouchard M, Feldman M. Human normal CTL clones: generation and properties. International Journal of Cancer. 31: 427-432. PMID 6219963 DOI: 10.1002/Ijc.2910310406  0.457
1983 Isakov N, Katzav S, Feldman M, Segal S. Loss of Expression of Transplantation Antigens Encoded by the H-2K Locus on Lewis Lung Carcinoma Cells and Its Relevance to the Tumor's Metastatic Properties Journal of the National Cancer Institute. 71: 139-145. DOI: 10.1093/Jnci/71.1.139  0.417
1982 Baetselier PD, Kapon A, Katsav S, Feldman M, Segal S. Selection of an immunogenic 3LL tumor subline following serial growth in vivo in the local presence of peritoneal macrophages. Advances in Experimental Medicine and Biology. 155: 281-288. PMID 7158485 DOI: 10.1007/978-1-4684-4394-3_29  0.377
1982 Isakov N, Feldman M, Segal S. Lactic dehydrogenase virus (LDV) impairs the antigen-presenting capacity of macrophages yet fails to affect their phagocytic activity. Immunobiology. 162: 15-27. PMID 7106838 DOI: 10.1016/S0171-2985(11)80013-6  0.409
1982 Gordon J, Holden HT, Segal S, Feldman M. Anti-tumor immunity in B-lymphocyte-deprived mice. III. Immunity to primary Moloney sarcoma virus-induced tumors. International Journal of Cancer. 29: 351-357. PMID 6978293 DOI: 10.1002/Ijc.2910290320  0.415
1982 Ron Y, Gorelik E, Feldman M, Segal S. Effect of splenectomy on the progression of postoperative pulmonary metastases of the 3LL tumor European Journal of Cancer and Clinical Oncology. 18: 391-397. PMID 6889517 DOI: 10.1016/0277-5379(82)90011-6  0.346
1982 Sher T, Haas M, Feldman M, Armuth V, Reshef T. Involvement of peritoneal macrophages and spleen stromal cells in X-irradiation-induced reticulum cell neoplasms in C57BL/6 mice. Leukemia Research. 6: 519-29. PMID 6755073 DOI: 10.1016/0145-2126(82)90009-1  0.323
1982 Isakov N, Feldman M, Segal S. Acute infection of mice with lactic dehydrogenase virus (LDV) impairs the antigen-presenting capacity of their macrophages. Cellular Immunology. 66: 317-332. PMID 6461420 DOI: 10.1016/0008-8749(82)90182-4  0.395
1982 Ron Y, Baetselier PD, Gordon J, Feldman M, Segal S. Impairment of Antigen-Specific T Cell Proliferative Response in B Cell Suppressed Mice Advances in Experimental Medicine and Biology. 149: 609-615. PMID 6183935 DOI: 10.1007/978-1-4684-9066-4_84  0.485
1982 Gorelik E, Feldman M, Segal S. Selection of 3LL tumor subline resistant to natural effector cells concomitantly selected for increased metastatic potency Cancer Immunology, Immunotherapy. 12: 105-109. DOI: 10.1007/Bf00205367  0.45
1981 Gorelik E, Segal S, Feldman M. On the mechanism of tumor "concomitant immunity". International Journal of Cancer. 27: 847-856. PMID 7287231 DOI: 10.1002/Ijc.2910270618  0.427
1981 Tzehoval E, Baetselier Pd, Feldman M, Segal S. The peritoneal antigen‐presenting macrophage: control and immunogenic properties of distinct subpopulations European Journal of Immunology. 11: 323-328. PMID 6972873 DOI: 10.1002/Eji.1830110411  0.438
1981 Ron Y, Baetselier PD, Gordon J, Feldman M, Segal S. Defective induction of antigen‐reactive proliferating T cells in B cell‐deprived mice European Journal of Immunology. 11: 964-968. PMID 6173237 DOI: 10.1002/Eji.1830111203  0.47
1981 Ron Y, Baetselier PD, Feldman M, Segal S. Involvement of the spleen in the control of the immunogenic and phagocytic function of thioglycollate‐induced macrophages European Journal of Immunology. 11: 608-611. PMID 6168471 DOI: 10.1002/Eji.1830110804  0.364
1980 Gorelik E, Fogel M, Segal S, Feldman M. The control of tumor metastasis. Results and Problems in Cell Differentiation. 11: 233-240. PMID 7444196 DOI: 10.1007/978-3-540-38267-6_30  0.392
1980 Clerici E, Schechter B, Feldman M. Enrichment of suppressor cell activity by hydrocortisone: suppression of in vitro activation of splenocytes from mice bearing Lewis lung carcinoma. International Journal of Cancer. 25: 349-354. PMID 6446525 DOI: 10.1002/Ijc.2910250308  0.483
1980 Tzehoval E, Segal S, Feldman M. Antigen-induced feedback suppression: antigen-specific initiator T cells fail to recruit new antigen-reactive cells in immunized mice. European Journal of Immunology. 10: 665-671. PMID 6158451 DOI: 10.1002/Eji.1830100903  0.501
1979 Treves AJ, Feldman M, Honsik C, Kaplan HS. In vivo activity of lymphocytes sensitized in vitro by antigen-fed macrophages: inhibition of lymphoma growth. Advances in Experimental Medicine and Biology. 114: 629-34. PMID 463661 DOI: 10.1007/978-1-4615-9101-6_103  0.481
1979 Isakov N, Hollander N, Segal S, Feldman M. An immunoregulatory factor associated with spleen cells from tumor-bearing animals. Iii. Characterization of the factor's target cells. International Journal of Cancer. 23: 410-414. PMID 374284 DOI: 10.1002/Ijc.2910230321  0.491
1979 Eisenthal A, Nachtigal D, Feldman M. Studies of allospecific suppressor cells in culture. Advances in Experimental Medicine and Biology. 114: 301-6. PMID 313670 DOI: 10.1007/978-1-4615-9101-6_48  0.447
1979 Schechter B, Feldman M. Suppressor cells prevent host resistance to tumor growth. Naturwissenschaften. 66: 140-146. PMID 311899 DOI: 10.1007/Bf00368707  0.471
1979 Gorelik E, Fogel M, Segal S, Feldman M. Tumor-associated antigenic differences between the primary and the descendant metastatic tumor cell populations. Journal of Supramolecular Structure. 12: 385-402. PMID 94933 DOI: 10.1002/Jss.400120309  0.419
1979 Eisenthal A, Nachtigal D, Feldman M. The generation of an allospecific suppressor factor in culture. Annals of the New York Academy of Sciences. 332: 367-77. PMID 93868 DOI: 10.1111/J.1749-6632.1979.Tb47131.X  0.44
1979 Schechter B, Feldman M. Immunosuppressor Cells In The Regulation Of The Antitumor Immune Response Cell Biology and Immunology of Leukocyte Function. 737-743. DOI: 10.1016/B978-0-12-569650-0.50098-X  0.462
1979 Fogel M, Gorelik E, Segal S, Feldman M. Antigenic Differences Exist Between Cell Surface Antigens Of The Local Tumor And Its Metastases Cell Biology and Immunology of Leukocyte Function. 715-723. DOI: 10.1016/B978-0-12-569650-0.50096-6  0.433
1979 Tzehoval E, Segal S, Stabinsky Y, Fridkin M, Spirer Z, Feldman M. Immunostimulation by an Ig derived tetrapeptide, tuftsin Springer Seminars in Immunopathology. 2: 205-214. DOI: 10.1007/978-3-642-67809-7_10  0.39
1978 Gorelik E, Segal S, Feldman M. Growth Of A Local Tumor Exerts A Specific Inhibitory Effect On Progression Of Lung Metastases International Journal of Cancer. 21: 617-625. PMID 659027 DOI: 10.1002/Ijc.2910210512  0.351
1978 Hollander N, Iskov N, Segal S, Feldman M. An immunoregulatory factor associated with spleen cells from tumor-bearing animals. II. Characterization of the cell populations involved in its production and release. International Journal of Cancer. 22: 471-478. PMID 359491 DOI: 10.1002/Ijc.2910220417  0.5
1978 Isakov N, Segal S, Hollander N, Feldman M. An immunoregulatory factor associated with spleen cells from tumor‐bearing animals. I. Effect on tumor growth and antibody production International Journal of Cancer. 22: 465-470. PMID 359490 DOI: 10.1002/Ijc.2910220416  0.476
1978 Fogel M, Segal S, Gorelik E, Feldman M. Specific cytotoxic lymphocytes against syngeneic tumors are generated in culture in the presence of syngeneic, but not xenogeneic, serum International Journal of Cancer. 22: 329-334. PMID 81185 DOI: 10.1002/Ijc.2910220317  0.435
1978 Treves AJ, Declève A, Lieberman M, Feldman M, Kaplan HS. Macrophage-mediated in vitro sensitization of lymphocytes. II. The detection of neo-antigens on transformed lymphocytes and passages of normal fibroblasts Journal of Immunology. 120: 1947-1951. DOI: 10.1007/Bf00205544  0.45
1977 Schechter B, Segal S, Feldman M. Enhancing lymphocytes in spleens of tumor-bearing mice: affinity chromatography on insolubilized histamine. International Journal of Cancer. 20: 239-246. PMID 892934 DOI: 10.1002/Ijc.2910200212  0.461
1977 Eisenthal A, Nachtigal D, Feldman M. Induction of allospecific suppressor T cells in vitro. Cellular Immunology. 34: 112-24. PMID 144022 DOI: 10.1016/0008-8749(77)90234-9  0.472
1977 Perah G, Feldman M. In vitro activation of the in vivo colony-forming units of the mouse yolk sac† Journal of Cellular Physiology. 91: 193-199. PMID 16935 DOI: 10.1002/Jcp.1040910205  0.366
1976 Treves AJ, Cohen IR, Schechter B, Feldman M. In vivo effects of lymphocytes sensitized in vitro against tumor cells. Annals of the New York Academy of Sciences. 276: 165-75. PMID 1088382 DOI: 10.1111/J.1749-6632.1976.Tb41644.X  0.428
1976 Treves AJ, Cohen IR, Feldman M. Suppressor factor secreted by T-lymphocytes from tumor-bearing mice. Journal of the National Cancer Institute. 57: 409-14. PMID 1087347 DOI: 10.1093/Jnci/57.2.409  0.431
1976 Manor Y, Treves AJ, Cohen IR, Feldman M. Transition from T cell protection to T cell enhancement during tumor growth in an allogeneic host. Transplantation. 22: 360-6. PMID 1086538 DOI: 10.1097/00007890-197610000-00007  0.474
1976 Waksal SD, Smolinsky S, Cohen IR, Feldman M. Transformation of thymocytes by thymus epithelium derived from AKR mice. Nature. 263: 512-4. PMID 1085917 DOI: 10.1038/263512A0  0.354
1976 Zan-Bar I, Nachtigal D, Feldman M. Studies on suppressor T cells in tolerance. Advances in Experimental Medicine and Biology. 66: 585-92. PMID 1083654 DOI: 10.1007/978-1-4613-4355-4_91  0.421
1976 Schechter B, Treves AJ, Feldman M. Specific cytotoxicity in vitro of lymphocytes sensitized in culture against tumor cells. Journal of the National Cancer Institute. 56: 975-9. PMID 994207 DOI: 10.1093/Jnci/56.5.975  0.477
1976 Schechter B, Feldman M. An in vitro assay of cell-mediated cytotoxicity. Terminal labeling with 3h-leucine. Transplantation. 22: 337-344. PMID 62427 DOI: 10.1097/00007890-197610000-00004  0.436
1975 Zan-Bar I, Nachtigal D, Feldman M. Mechanisms in immune tolerance. III. Immunosuppression and the induction of tolerance--synergism and antagonism. Cellular Immunology. 17: 215-27. PMID 1125988 DOI: 10.1016/S0008-8749(75)80021-9  0.339
1975 Nachtigal D, Zan-Bar I, Feldman M. The role of specific suppressor T cells in immune tolerance. Transplantation Reviews. 26: 87-105. PMID 1101472 DOI: 10.1111/J.1600-065X.1975.Tb00176.X  0.411
1975 Zan-Bar I, Nachtigal D, Feldman M. Mechanisms in immune tolerance. II. Specific immunosuppression by T lymphocytes of B memory cells in mice made tolerant to HSA. Cellular Immunology. 17: 202-14. PMID 1079166 DOI: 10.1016/S0008-8749(75)80020-7  0.475
1975 Waksal SD, Cohen IR, Waksal HW, Wekerle H, St Pierre RL, Feldman M. Induction of T-cells differentiation in vitro by thymus epithelial cells. Annals of the New York Academy of Sciences. 249: 492-8. PMID 236721 DOI: 10.1111/J.1749-6632.1975.Tb29098.X  0.44
1975 Cohen IR, Feldman M. Cellular interactions controlling the immune reactivity of T-lymphocytes. Annals of the New York Academy of Sciences. 249: 106-15. PMID 124152 DOI: 10.1111/J.1749-6632.1975.Tb29061.X  0.453
1975 Treves AJ, Cohen IR, Feldman M. Immunotherapy of lethal metastases by lymphocytes sensitized against tumor cells in vitro. Journal of the National Cancer Institute. 54: 777-780. DOI: 10.1093/Jnci/54.3.777  0.44
1975 Zagury D, Bernard J, Thierness N, Feldman M, Berke G. Isolation and characterization of individual functionally reactive cytotoxic T lymphocytes: conjugation, killing and recycling at the single cell level European Journal of Immunology. 5: 818-822. DOI: 10.1002/Eji.1830051205  0.475
1975 Berke G, Gabison D, Feldman M. The frequency of effector cells in populations containing cytotoxic T lymphocytes European Journal of Immunology. 5: 813-818. DOI: 10.1002/Eji.1830051204  0.459
1974 Treves AJ, Carnaud C, Trainin N, Feldman M, Cohen IR. Enhancing T lymphocytes from tumor-bearing mice suppress host resistance to a syngeneic tumor. European Journal of Immunology. 4: 722-7. PMID 4547711 DOI: 10.1002/Eji.1830041104  0.471
1974 Stavy L, Cohen IR, Feldman M. Stimulation of rat lymphocyte proliferation by hydrocortisone during the induction of cell-mediated immunity in vitro. Transplantation. 17: 173-9. PMID 4544081 DOI: 10.1097/00007890-197402000-00004  0.399
1974 Zan-Bar I, Nachtigal D, Feldman M. Mechanisms in immune tolerance. I. A specific block of immunological memory in HSA-tolerant mice. Cellular Immunology. 10: 19-30. PMID 4477048 DOI: 10.1016/0008-8749(74)90147-6  0.388
1974 Hollander N, Ginsburg H, Feldman M. In vitro generation of memory lymphocytes reactive to transplantation antigens Journal of Experimental Medicine. 140: 1057-1067. PMID 4427086 DOI: 10.1084/Jem.140.4.1057  0.415
1974 Wekerle H, Kölsch E, Feldman M. T cell recognition of cell-surface antigens. II. Antigen recognition is necessary yet not sufficient for triggering T cell-mediated immunity. European Journal of Immunology. 4: 246-50. PMID 4212381 DOI: 10.1002/Eji.1830040404  0.43
1974 Wekerle H, Feldman M. T cell recognition of cell surface antigens. I. Specificity. European Journal of Immunology. 4: 240-6. PMID 4137229 DOI: 10.1002/Eji.1830040403  0.432
1974 Feldman M, Globerson A. Reception of immunogenic signals by lymphocytes. Current Topics in Developmental Biology. 8: 1-40. PMID 4133032 DOI: 10.1016/S0070-2153(08)60604-3  0.471
1973 Kunin S, Shearer GM, Globerson A, Feldman M. Oligocellular mechanism in the production of antibodies: in vitro response to a haptenic determinant. Cellular Immunology. 8: 455-69. PMID 4725867 DOI: 10.1016/0008-8749(73)90137-8  0.43
1973 Stavy L, Cohen IR, Feldman M. The effect of hydrocortisone on lymphocyte-mediated cytolysis. Cellular Immunology. 7: 302-12. PMID 4704919 DOI: 10.1016/0008-8749(73)90252-9  0.393
1973 Wekerle H, Cohen IR, Feldman M. Thymus reticulum cell cultures confer T cell properties on spleen cells from thymus-deprived animals. European Journal of Immunology. 3: 745-8. PMID 4544457 DOI: 10.1002/Eji.1830031202  0.43
1973 Wekerle H, Cohen IR, Feldman M. Lymphocyte receptors for autoantigens, autologous serum inhibits self-recognition. Nature: New Biology. 241: 25-6. PMID 4540588 DOI: 10.1038/Newbio241025A0  0.384
1973 Bleiberg I, Perah G, Feldman M. Effect of Testosterone on the Formation of Erythroid Spleen Colonies From Fetal Liver Precursor Cells Blood. 41: 285-291. DOI: 10.1182/Blood.V41.2.285.285  0.367
1972 Stavy L, Treves AJ, Feldman M. Capacity of thymic cells to effect target cell lysis following treatment with concanavalin A. Cellular Immunology. 3: 623-8. PMID 5023517 DOI: 10.1016/0008-8749(72)90124-4  0.394
1972 Nakamura I, Segal S, Globerson A, Feldman M. DNA replication as a prerequisite for the induction of primary antibody response. Cellular Immunology. 4: 351-66. PMID 4559166 DOI: 10.1016/0008-8749(72)90038-X  0.37
1972 Kunin S, Shearer GM, Globerson A, Feldman M. Immunogenic function of macrophages: in vitro production of antibodies to a hapten-carrier conjugate. Cellular Immunology. 5: 288-95. PMID 4538497 DOI: 10.1016/0008-8749(72)90054-8  0.437
1972 Lonai P, Wekerle H, Feldman M. Fractionation of specific antigen-reactive cells in an in vitro system of cell-mediated immunity. Nature: New Biology. 235: 235-6. PMID 4502411 DOI: 10.1038/Newbio235235A0  0.48
1972 Feldman M, Cohen IR, Wekerle H. T-cell mediated immunity in vitro: an analysis of antigen recognition and target cell lysis. Transplantation Reviews. 12: 57-90. PMID 4119632 DOI: 10.1111/J.1600-065X.1972.Tb00053.X  0.46
1972 Segal S, Cohen IR, Feldman M. Thymus-derived lymphocytes: humoral and cellular reactions distinguished by hydrocortisone. Science (New York, N.Y.). 175: 1126-8. PMID 4110485 DOI: 10.1126/Science.175.4026.1126  0.445
1972 Cohen IR, Feldman M. The lysis of fibroblasts by lymphocytes sensitized in vitro: specific antigen activates a nonspecific effect. Cellular Immunology. 1: 521-35. PMID 4108697 DOI: 10.1016/0008-8749(70)90039-0  0.406
1971 Clark WR, Berke G, Feldman M, Sarid S. Macromolecular synthesis during the sensitization of rat lymphocytes on mouse fibroblasts in vitro Immunochemistry. 8: 487-492,IN5-IN6,493-. PMID 5556923 DOI: 10.1016/0019-2791(71)90400-9  0.331
1971 Cohen IR, Globerson A, Feldman M. Rejection of tumor allografts by mouse spleen cells sensitized in vitro. The Journal of Experimental Medicine. 133: 821-33. PMID 5547058 DOI: 10.1084/Jem.133.4.821  0.519
1971 Cohen IR, Stavy L, Feldman M. Glucocorticoids and cellular immunity in vitro. Facilitation of the sensitization phase and inhibition of the effector phase of a lymphocyte anti-fibroblast reaction. The Journal of Experimental Medicine. 132: 1055-70. PMID 5511566 DOI: 10.1084/Jem.132.6.1055  0.361
1971 Kunin S, Shearer GM, Segal S, Globerson A, Feldman M. A bicellular mechanism in the immune response to chemically defined antigens. 3. Interaction of thymus and bone marrow-derived cells. Cellular Immunology. 2: 229-38. PMID 5166043 DOI: 10.1016/0008-8749(71)90042-6  0.4
1971 Segal S, Globerson A, Feldman M. A bicellular mechanism in the immune response to chemically defined antigens. II. Immunological tolerance. Cellular Immunology. 2: 222-8. PMID 5166042 DOI: 10.1016/0008-8749(71)90041-4  0.355
1971 Ginsburg H, Hollander N, Feldman M. The development of hypersensitive lymphocytes in cell culture Journal of Experimental Medicine. 134: 1062-1082. PMID 5098056 DOI: 10.1084/Jem.134.4.1062  0.468
1971 Lonai P, Feldman M. Cooperation of lymphoid cells in an in vitro graft reaction system. II. The "bone marrow-derived" cell. Transplantation. 11: 446-456. PMID 5089508 DOI: 10.1097/00007890-197105000-00003  0.336
1971 Stavy L, Treves AJ, Feldman M. Effect of concanavalin A on lymphocyte-mediated cytotoxicity. Nature. 232: 56-8. PMID 4933177 DOI: 10.1038/232056A0  0.432
1971 Lonai P, Clark WR, Feldman M. Participation of θ-bearing cell in an in vitro assay of transplantation immunity Nature. 229: 566-567. PMID 4925357 DOI: 10.1038/229566A0  0.403
1971 Berke G, Clark WR, Feldman M. In vitro induction of a heterograft reaction: Immunological parameters of the sensitization of rat lymphocytes against mouse cells in vitro Transplantation. 12: 237-248. PMID 4398839 DOI: 10.1097/00007890-197110000-00001  0.354
1971 Cohen IR, Globerson A, Feldman M. Autosensitization in vitro. The Journal of Experimental Medicine. 133: 834-45. PMID 4396043 DOI: 10.1084/Jem.133.4.834  0.441
1971 Segal S, Globerson A, Feldman M. A bicellular mechanism in the immune response to chemically defined antigens. I. Antibody formation in vitro. Cellular Immunology. 2: 205-21. PMID 4107677 DOI: 10.1016/0008-8749(71)90040-2  0.397
1970 Segal S, Globerson A, Feldman M, Haimovich J, Sela M. In vitro induction of a primary response to the dinitrophenyl determinant. The Journal of Experimental Medicine. 131: 93-9. PMID 5460614 DOI: 10.1084/Jem.131.1.93  0.349
1970 Lonai P, Feldman M. Cooperation of lymphoid cells in an in vitro graft reaction system. The role of the thymus cell. Transplantation. 10: 372-381. PMID 4099185 DOI: 10.1097/00007890-197011000-00003  0.439
1970 Givol D, Haimovich J, Segal S, Globerson A, Feldman M. Specific Blocking of in vitro Antibody Response by Affinity Labeling Reagents Protides of the Biological Fluids. 17: 59-61. DOI: 10.1016/B978-0-08-015566-1.50012-5  0.374
1969 Segal S, Globerson A, Feldman M, Haimovich J, Givol D. Specific blocking in vitro of antibody synthesis by affinity labelling reagents. Nature. 223: 1374-5. PMID 5809514 DOI: 10.1038/2231374A0  0.401
1969 Bleiberg I, Feldman M. On the regulation of hemopoietic spleen colonies produced by embryonic and adult cells. Developmental Biology. 19: 566-580. PMID 4890853 DOI: 10.1016/0012-1606(69)90038-4  0.379
1968 Gershon H, Bauminger S, Sela M, Feldman M. Studies on the competence of single cells to produce antibodies of two specificities. The Journal of Experimental Medicine. 128: 223-33. PMID 5662016 DOI: 10.1084/Jem.128.1.223  0.415
1967 Bleiberg I, Liron M, Feldman M. Studies on the regulation of hemopoietic spleen colonies. Blood. 29: 469-480. DOI: 10.1182/Blood.V29.4.469.469  0.388
1965 Yaffe D, Feldman M. The formation of hybrid multinucleated muscle fibers from myoblasts of different genetic origin Developmental Biology. 11: 300-317. PMID 14332576 DOI: 10.1016/0012-1606(65)90062-X  0.306
1965 Mekori T, Feldman M. Protection Of X-Irradiated Mice By "Cloned" Haemopoietic Cells. Transplantation. 3: 98-113. PMID 14251691 DOI: 10.1097/00007890-196501000-00012  0.346
1965 Bleiberg I, Liron M, Feldman M. Reversion by erythropoietin of the suppression of erythroid clones caused by transfusion-induced polycythemia. Transplantation. 3: 706-710. PMID 5864171 DOI: 10.1097/00007890-196511000-00002  0.354
1965 Mekori T, Chieco-Bianci L, Feldman M. Production of clones of lymphoid cell populations. Nature. 206: 367-368. PMID 5837029 DOI: 10.1038/206367A0  0.314
1964 SCHECHTER I, BAUMINGER S, SELA M, NACHTIGAL D, FELDMAN M. IMMUNE RESPONSE TO POLYPEPTIDYL PROTEINS IN RABBITS TOLERANT TO THE PROTEIN CARRIERS. Immunochemistry. 1: 249-65. PMID 14250779 DOI: 10.1016/0019-2791(64)90026-6  0.336
1964 FELDMAN M, GLOBERSON A. THE ROLE OF THE THYMUS IN RESTORING IMMUNOLOGICAL REACTIVITY AND LYMPHOID CELL DIFFERENTIATION IN X-IRRADIATED ADULT MICE. Annals of the New York Academy of Sciences. 120: 182-90. PMID 14233863 DOI: 10.1111/J.1749-6632.1964.Tb34716.X  0.345
1964 GLOBERSON A, FELDMAN M. ANTIGENIC SPECIFICITY OF BENZO(A)PYRENE-INDUCED SARCOMAS. Journal of the National Cancer Institute. 32: 1229-43. PMID 14191397 DOI: 10.1093/Jnci/32.6.1229  0.355
1964 GLOBERSON A, FELDMAN M. ROLE OF THE THYMUS IN RESTORATION OF IMMUNE REACTIVITY AND LYMPHOID REGENERATION IN IRRADIATED MICE. Transplantation. 2: 212-27. PMID 14133693 DOI: 10.1097/00007890-196403000-00006  0.398
1961 Feldman M, Globerson A. Studies on the mechanism of immunological enhancement of tumor grafts Plastic and Reconstructive Surgery. 28: 98. DOI: 10.1097/00006534-196107000-00064  0.316
1960 FELDMAN M, ELSON D, GLOBERSON A. Antibodies in ribonucleoproteins. Nature. 185: 317-9. PMID 13822041 DOI: 10.1038/185317A0  0.31
1960 Feldman M, Globerson A. Studies on the mechanism of immunological enhancement of tumor grafts. Journal of the National Cancer Institute. 25: 631-648. DOI: 10.1093/Jnci/25.3.631  0.316
1959 Yaffe D, Feldman M. Immunogenetic changes induced in tumors grown in radiation chimeras Journal of the National Cancer Institute. 23: 133-151. PMID 13846337 DOI: 10.1093/Jnci/23.1.133  0.415
1959 Feldman M, Yaffe D. Immunogenetic studies on x-irradiated mice treated with hematopoietic cells and grafted with tumor tissues Journal of the National Cancer Institute. 23: 109-131. PMID 13673273 DOI: 10.1093/Jnci/23.1.109  0.433
1958 Feldman M, Yaffe D. Immunogenetic studies on x-irradiated mice treated with homologous hematopoietic cells Journal of the National Cancer Institute. 21: 697-712. PMID 13588369 DOI: 10.1093/Jnci/21.4.697  0.373
1958 Feldman M, Sachs L. Immunogenetic Properties of Tumors That Have Acquired Homotransplant-ability Journal of the National Cancer Institute. 20: 513-539. DOI: 10.1093/Jnci/20.3.513  0.317
1957 Feldman M, Yaffe D. Production of organ-specific antibodies following an induction of tolerance to antigens of heterologous organs Nature. 179: 1353-1354. PMID 13451622 DOI: 10.1038/1791353A0  0.336
Show low-probability matches.